Related Experiment Video
Updated: Aug 16, 2026
07:44
Identifying Protein-protein Interaction Sites Using Peptide Arrays
Published on: November 18, 2014
Peptide binding identifies an ERalpha conformation that generates selective activity in multiple in vitro assays
Christopher J Larson1, Deborah L Osburn, Katherine Schmitz
1Department of Molecular & Cell Biology and New Leads Discovery Ligand Pharmaceuticals, San Diego, CA 92121, USA.
Journal of Biomolecular Screening
|August 17, 2005
Summary
Peptide recruitment to the estrogen receptor (ER) better predicts how ER-targeting drugs like tamoxifen behave in cells than traditional assays. This offers a more accurate way to understand drug efficacy.
Area of Science:
- Endocrinology
- Molecular Pharmacology
- Cell Biology
Background:
- Estrogen receptor (ER) ligands exhibit distinct in vitro and in vivo effects compared to native estrogen.
- Ligand-induced conformational changes in ER modulate interactions with cofactors and estrogen response elements (EREs), influencing biological outcomes.
- Previous studies utilized affinity-selected peptides to investigate ER conformational shifts upon ligand binding.
Purpose of the Study:
- To characterize peptide recruitment to liganded ER under cellular conditions.
- To evaluate peptide recruitment as a predictor of ER ligand activity.
- To compare peptide recruitment assay efficacy against traditional cotransfection transactivation assays.
Main Methods:
- Utilized affinity-selected peptides to probe ER conformation.
- Assessed peptide recruitment to liganded ER in cellular contexts.
- Performed cotransfection transactivation assays for comparison.
Main Results:
- Demonstrated that specific peptides can be recruited to liganded ER within cells.
- Found peptide recruitment to be a more accurate predictor of ER ligand agonist activity.
- Showed peptide recruitment assays outperform canonical transactivation assays in certain cellular contexts.
Conclusions:
- Peptide recruitment to liganded ER provides a superior method for predicting ER ligand behavior in vivo.
- This approach offers a more nuanced understanding of ER ligand pharmacology.
- The findings suggest a more reliable assay for evaluating ER-targeting therapeutics.
